Developer docs
API playgroundTry for free, no card

Search company profiles

GLSA

Full company profile

uuid000fu9i

Namestring
GLSA
Legal namestring
Global Life Sciences Alliance, LLC
Company typeenum
Private
Founded yearint
2020
Descriptiontext

GLSA (Global Life Sciences Alliance, LLC) is a Philadelphia-based private network aggregator and fractionalized consulting services platform serving the life sciences industry. Founded in 2020, the company operates a curated ecosystem of 200+ vetted global partners including CDMOs, CROs, specialized laboratories, eClinical technology providers, and fractionalized senior executives (fractional CMOs, regulatory experts, clinical operations leaders). GLSA connects emerging biotech companies, pharmaceutical sponsors, clinical research sites, and CROs with on-demand expertise and service providers across the full preclinical-to-clinical development continuum, from IND-enabling studies and bioanalysis through Phase I-IV clinical trials, data management, licensing, and investor readiness support.

GLSA's service portfolio spans more than 15 distinct offerings including Preclinical & IND-Enabling Solutions, Global Clinical Research Solutions, Emerging Biotech Solutions, AI Drug Development & Clinical Research, Bioanalysis & Translational Science, eClinical Technologies (RTSM, EDC), Lab & Diagnostics, IRT & Clinical Supply Chain, Licensing & Strategic Partnering, Patient Recruitment & Diversity, Data Management & Biostatistics, Fractional HR, Talent Acquisition, and Business Services. The company also operates GLSA Site Nexus, a private community platform for clinical research site staff, along with sub-brands including GLSA Community Partners, Friends of Chris Matheus (FOCM), Women of Life Sciences (WoLS), and GLSA Accelerated Partnering. AI capabilities are positioned across clinical operations optimization, patient matching, predictive feasibility, and AI-assisted regulatory writing, though these are delivered primarily as advisory and integration services over third-party technology stacks rather than as proprietary AI products.

The business model is professional services and managed network services revenue, delivered through quote-based project, fractional, and retainer arrangements on a monthly billing cadence. Pricing is not publicly disclosed. GLSA employs 11-50 staff led by co-founders Denise McNerney (Chief Strategy & Operations Officer) and Chris Matheus (Chief Commercial & Networking Officer), supported by a global advisory network whose members contribute fractional capacity. Go-to-market is enterprise field sales driven by the founders' direct relationships, supplemented by channel distribution through the 200-partner network. The company is founder-controlled with no disclosed institutional investment or external funding rounds identified.

Short descriptiontext

GLSA is a Philadelphia-based private network aggregator connecting life sciences sponsors, emerging biotechs, CROs, and clinical research sites with 200+ vetted global partners and fractionalized senior experts across preclinical and clinical development. Founded in 2020, it offers consulting, site community (GLSA Site Nexus), AI-enabled research services, and operational support on a fractional model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPhiladelphia, United States
HQ citystring
Philadelphia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical research services, preclinical development consulting, biotech advisory services, fractional life sciences experts, clinical trial solutions
Industry1 code
PRIMARYBPAHALAH
Technical & Scientific Expert Networks
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
  • Management Consulting Services54161
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
  • Services-Management Services8741
Product category
Life Sciences Consulting Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Professional Services & Consulting
TypeProfessional Services
Description

Fractionalized expertise and consulting services provided through a network of vetted partners and specialists. Services are offered on-demand, project-based, or retainer arrangements tailored to preclinical and clinical research needs.

globallifesciencesalliance.com
2Network Partnership Services
TypeManaged Services
Description

GLSA Network facilitates curated connections between sponsors, CROs, sites and service providers, with partners able to offer services as full projects, fractional support, or specialized solutions.

globallifesciencesalliance.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Fractionalized/On-Demand Support
ModelSubscriptionBilling cadenceMonthly
Notes

Flexible fractional leadership and expert support available on subscription or project basis. Services scale with client needs without commitment to full-time hires.

globallifesciencesalliance.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1GLSA Site Nexus
Description

A private, curated community exclusively for Clinical Research Site Staff providing study opportunities, peer networking, on-demand experts, and site education.

sites.globallifesciencesalliance.com
+5 more records
Core offering1 text field

GLSA (Global Life Sciences Alliance) operates a curated network of 200+ fractionalized experts, CDMOs, CROs, labs, and specialized service partners that delivers end-to-end preclinical and clinical development solutions to life sciences organizations. The company provides on-demand, project-based, or retainer consulting arrangements covering discovery, IND-enabling studies, clinical trial management, vendor selection, bioanalysis, eClinical technologies, patient recruitment, licensing, and investor connections. Its core commercial model is relationship-driven direct engagement with sponsors, biotechs, and CROs, supplemented by a private community (GLSA Site Nexus) for clinical research sites.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GLSA (Global Life Sciences Alliance) is a collaborative network of fractionalized experts, CDMOs, CROs, labs, and specialized service partners delivering preclinical and clinical development solutions across the life sciences ecosystem. The company offers a portfolio of interconnected service offerings including Preclinical & IND-Enabling Solutions, Global Clinical Research Solutions, Emerging Biotech Solutions, AI Drug Development & Clinical Research, Bioanalysis & Translational Science, eClinical Technologies (RTSM, EDC), Lab & Diagnostic Solutions, IRT & Clinical Supply Chain Solutions, Licensing & Strategic Partnering, Patient Recruitment & Diversity, Investor Readiness & Connections, Data Management & Biostatistics, and GLSA Site Nexus (a private community for clinical research site staff). Additional services include Fractional HR Services, Talent Acquisition, and Business Services. GLSA's network comprises 200+ global partners with over 100 years of combined experience, supporting organizations from early discovery through clinical trials, regulatory approval, licensing, and commercialization.

Product and service18 records
1Preclinical & IND-Enabling Solutions
CategoryPreclinical Development Services
Description

Discovery, translational strategy, and IND-readiness support including toxicology, pharmacology, and IND-enabling studies delivered through fractional leadership and vetted global partners for biotech and pharma sponsors.

2Global Clinical Research Solutions
CategoryClinical Trial Management Services
Description

End-to-end Phase I-IV clinical trial solutions delivered through global CRO partnerships, site networks, GLSA Site Nexus, eClinical systems, and specialized operational leadership for sponsors and emerging biotechs.

3Emerging Biotech Solutions
CategoryBiotech Advisory Services
Description

Fractionalized executive leadership and full-service preclinical and clinical solutions for emerging biotech companies, supporting development from seed through clinical-stage execution.

4AI Drug Development & Clinical Research
CategoryAI-Enabled Clinical Research Services
Description

AI-powered predictive modeling, trial optimization, and predictive research integrating AI and machine learning across preclinical and clinical development to improve protocol optimization, feasibility, and patient matching.

5Bioanalysis & Translational Science
CategoryBioanalytical Services
Description

Strategic bioanalysis, assay development, validation, and scientific oversight supporting small molecule, large molecule, translational, and biomarker programs with regulatory readiness and data integrity.

6eClinical Technologies
CategoryClinical Technology Services
Description

Advanced eClinical systems including RTSM, EDC, AI-enabled workflows, and cybersecurity-focused technology infrastructure for digital trial execution, data integrity, and regulatory compliance.

7Lab & Diagnostic Solutions
CategoryLaboratory & Diagnostic Services
Description

Central labs, genomic services, biomarker strategy, and diagnostic infrastructure supporting precision medicine, translational research, and clinical trials from discovery through commercialization.

8IRT & Clinical Supply Chain Solutions
CategoryClinical Supply Chain Services
Description

Integrated IRT, RTSM, global supply chain, cold-chain logistics, and investigational distribution solutions ensuring chain of custody, inventory transparency, and uninterrupted product delivery.

9Licensing & Strategic Partnering
CategoryLicensing & Business Development Services
Description

Global licensing, strategic partnering, asset commercialization, investor readiness, diligence preparation, and commercialization planning for biotech and life sciences innovators.

10Patient Recruitment, Advocacy & Diversity
CategoryPatient Recruitment Services
Description

Patient recruitment experts, advocacy networks, call centers, and diversity-focused engagement solutions improving enrollment, retention, and representation aligned with FDA diversity initiatives.

11GLSA Investor Readiness & Connections
CategoryInvestor Readiness Services
Description

Investor readiness, strategic growth, and capital alignment solutions supporting funding preparation, investor engagement, partnerships, and scalable growth for life sciences companies.

12Data Management & Biostatistics
CategoryData Management & Biostatistics Services
Description

Biostatistics, clinical data management, governance, endpoint analysis, and regulatory reporting solutions improving trial precision, compliance, and strategic decision-making.

13GLSA Site Nexus
CategoryClinical Research Site Community Platform
Description

Private, curated community exclusively for Clinical Research Site Staff providing study opportunities, quick feasibility requests, peer networking, on-demand experts, and site education, certifications, and training.

14Fractional HR Services
CategoryFractional HR Services
Description

Fractional human resources leadership and talent acquisition support for life sciences companies, including HR policy development, compliance audits, recruitment strategy, and organizational culture building.

15Talent Acquisition & Executive Search
CategoryExecutive Search & Talent Acquisition
Description

Life sciences talent acquisition connecting organizations with high-performing teams and helping professionals find meaningful career opportunities in biotech, pharma, and life sciences.

16Clinical Supply Chain & Logistics Consulting
CategoryClinical Supply Chain Consulting
Description

End-to-end clinical trial supply chain and logistics consulting including packaging, labeling, global distribution, cold-chain coordination, and last-mile delivery for investigational products.

17Business Services
CategoryBusiness Services
Description

Strategic marketing, brand development, go-to-market execution, organizational development, and change management for life sciences companies.

18GLSA Network Partner Services
CategoryPartner Network Services
Description

Network of trusted CDMOs, CROs, labs, technology providers, and specialized service partners delivering end-to-end preclinical and clinical solutions to sponsors, sites, and emerging biotech companies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

GLSA Site Nexus connects sponsors and CROs with qualified clinical research sites. Sites gain visibility, study opportunities, peer networking, and access to shared resources and educational opportunities through a private community.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Senior advisors including fractional CMOs, regulatory experts, and specialized executives providing on-demand strategic guidance across preclinical and clinical development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Manufacturing and development partners within the 200+ partner network supporting preclinical through commercial production capabilities.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Global CRO partnerships enabling clinical trial execution, operational support, and study management across all phases.

5Specialized Laboratories & Diagnostics
Strategic tierCoreTypeTechnology or Integration
Description

Pre-vetted lab partners for bioanalysis, biomarkers, central labs, genomics, and diagnostic services supporting translational research and clinical trials.

globallifesciencesalliance.com
Strategic tierMajorTypeTechnology or Integration
Description

Technology partners providing EDC, CTMS, eCOA, ePRO, RTSM, and integrated clinical platforms for digital trial infrastructure.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Digital marketing, community engagement, and AI-supported patient matching partners helping trials accelerate enrollment and improve retention.

8Women of Life Sciences (WoLS)
Strategic tierMinorTypeGTM or Marketing Partner
Description

LinkedIn community of 400+ women in life sciences with events, conversations, and networking initiatives supported by GLSA.

globallifesciencesalliance.com
9FOCM (Friends of Chris Matheus)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Networking membership group hosting monthly virtual events for life sciences professionals, sponsors, and GLSA community.

globallifesciencesalliance.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Syneos Health provides clinical development and commercial services with a biopharmaceutical acceleration model. Comparable to GLSA's end-to-end positioning across clinical and commercialization, though Syneos operates owned delivery infrastructure.

TypeDirect peer
Description

WCG provides clinical trial solutions including IRB review, site optimization, and study activation services. Comparable to GLSA Site Nexus in particular, given both focus on site enablement, study startup acceleration, and sponsor-site connections across the clinical research ecosystem.

TypeBroad incumbent
Description

IQVIA is the largest global CRO and life sciences services conglomerate, offering clinical operations, real-world evidence, and technology. Comparable to GLSA in serving sponsors and biotechs across the full clinical development lifecycle, but at vastly greater scale and with owned infrastructure rather than a partner aggregator model.

TypeBroad incumbent
Description

Charles River provides preclinical CRO services, CDMO capabilities, and research models. Comparable to GLSA's preclinical and IND-enabling solutions offering, though Charles River operates owned lab infrastructure at global scale.

TypeBroad incumbent
Description

Fortrea (spun out from Labcorp) is a major CRO providing clinical development, laboratory, and commercialization services. Comparable to GLSA across clinical operations and central lab services, though at much larger scale with owned assets.

TypeBroad incumbent
Description

Medpace is a mid-to-large CRO focused on emerging and mid-sized biotechs with full-service clinical development. Direct overlap with GLSA's primary emerging biotech segment, though Medpace operates owned regional operations versus GLSA's partner aggregator model.

TypeBroad incumbent
Description

Parexel is a global CRO offering clinical operations, regulatory, biostatistics, and consulting services. Comparable to GLSA across clinical research solutions and regulatory services, though Parexel operates owned global infrastructure.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-sized CRO specializing in complex clinical trials across multiple therapeutic areas. Comparable to GLSA in targeting mid-sized biotech and emerging pharma with flexible engagement models, though Worldwide delivers via owned operations.

TypeBroad incumbent
Description

ICON is a leading global CRO offering clinical research, consulting, and laboratory services across all phases. Comparable to GLSA in serving emerging biotechs and sponsors with end-to-end trial services, though ICON operates an owned-delivery model versus GLSA's partner-network aggregator approach.

10BioIQ (or equivalent fractional biotech services firm)
TypeEmerging player
Description

BioIQ and similar fractional biotech advisory firms provide fractional leadership and operational support to emerging biotechs. Comparable to GLSA's Emerging Biotech Solutions and fractional executive offerings, though typically narrower in service scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GLSA

Life Sciences Consulting Servicesgloballifesciencesalliance.com

GLSA is a Philadelphia-based private network aggregator connecting life sciences sponsors, emerging biotechs, CROs, and clinical research sites with 200+ vetted global partners and fractionalized senior experts across preclinical and clinical development. Founded in 2020, it offers consulting, site community (GLSA Site Nexus), AI-enabled research services, and operational support on a fractional model.

What GLSA does

GLSA (Global Life Sciences Alliance, LLC) is a Philadelphia-based private network aggregator and fractionalized consulting services platform serving the life sciences industry. Founded in 2020, the company operates a curated ecosystem of 200+ vetted global partners including CDMOs, CROs, specialized laboratories, eClinical technology providers, and fractionalized senior executives (fractional CMOs, regulatory experts, clinical operations leaders). GLSA connects emerging biotech companies, pharmaceutical sponsors, clinical research sites, and CROs with on-demand expertise and service providers across the full preclinical-to-clinical development continuum, from IND-enabling studies and bioanalysis through Phase I-IV clinical trials, data management, licensing, and investor readiness support.

GLSA's service portfolio spans more than 15 distinct offerings including Preclinical & IND-Enabling Solutions, Global Clinical Research Solutions, Emerging Biotech Solutions, AI Drug Development & Clinical Research, Bioanalysis & Translational Science, eClinical Technologies (RTSM, EDC), Lab & Diagnostics, IRT & Clinical Supply Chain, Licensing & Strategic Partnering, Patient Recruitment & Diversity, Data Management & Biostatistics, Fractional HR, Talent Acquisition, and Business Services. The company also operates GLSA Site Nexus, a private community platform for clinical research site staff, along with sub-brands including GLSA Community Partners, Friends of Chris Matheus (FOCM), Women of Life Sciences (WoLS), and GLSA Accelerated Partnering. AI capabilities are positioned across clinical operations optimization, patient matching, predictive feasibility, and AI-assisted regulatory writing, though these are delivered primarily as advisory and integration services over third-party technology stacks rather than as proprietary AI products.

The business model is professional services and managed network services revenue, delivered through quote-based project, fractional, and retainer arrangements on a monthly billing cadence. Pricing is not publicly disclosed. GLSA employs 11-50 staff led by co-founders Denise McNerney (Chief Strategy & Operations Officer) and Chris Matheus (Chief Commercial & Networking Officer), supported by a global advisory network whose members contribute fractional capacity. Go-to-market is enterprise field sales driven by the founders' direct relationships, supplemented by channel distribution through the 200-partner network. The company is founder-controlled with no disclosed institutional investment or external funding rounds identified.

GLSA firmographics

Firmographics
Name
GLSA
Legal name
Global Life Sciences Alliance, LLC
Website
https://globallifesciencesalliance.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
GLSA is a Philadelphia-based private network aggregator connecting life sciences sponsors, emerging biotechs, CROs, and clinical research sites with 200+ vetted global partners and fractionalized senior experts across preclinical and clinical development. Founded in 2020, it offers consulting, site community (GLSA Site Nexus), AI-enabled research services, and operational support on a fractional model.
Ownership category
akta.pro rank

GLSA industry classification

Industry
Product category
Life Sciences Consulting Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742), Services-Management Services (8741)
akta.pro industry
PRIMARYBPAHALAH
Technical & Scientific Expert Networks

Keywords

  • Clinical research services
  • Preclinical development consulting
  • Biotech advisory services
  • Fractional life sciences experts
  • Clinical trial solutions

Where GLSA is headquartered

Location

Headquarters

HQ city
Philadelphia
HQ country
United States
HQ region
North America

Markets served

GLSA business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Professional Services & Consulting: Fractionalized expertise and consulting services provided through a network of vetted partners and specialists. Services are offered on-demand, project-based, or retainer arrangements tailored to preclinical and clinical research needs.
  2. Network Partnership Services: GLSA Network facilitates curated connections between sponsors, CROs, sites and service providers, with partners able to offer services as full projects, fractional support, or specialized solutions.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyFractionalized/On-Demand Support

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

GLSA product offering

Product offering

Core offering

GLSA (Global Life Sciences Alliance) operates a curated network of 200+ fractionalized experts, CDMOs, CROs, labs, and specialized service partners that delivers end-to-end preclinical and clinical development solutions to life sciences organizations. The company provides on-demand, project-based, or retainer consulting arrangements covering discovery, IND-enabling studies, clinical trial management, vendor selection, bioanalysis, eClinical technologies, patient recruitment, licensing, and investor connections. Its core commercial model is relationship-driven direct engagement with sponsors, biotechs, and CROs, supplemented by a private community (GLSA Site Nexus) for clinical research sites.

Product overview

GLSA (Global Life Sciences Alliance) is a collaborative network of fractionalized experts, CDMOs, CROs, labs, and specialized service partners delivering preclinical and clinical development solutions across the life sciences ecosystem. The company offers a portfolio of interconnected service offerings including Preclinical & IND-Enabling Solutions, Global Clinical Research Solutions, Emerging Biotech Solutions, AI Drug Development & Clinical Research, Bioanalysis & Translational Science, eClinical Technologies (RTSM, EDC), Lab & Diagnostic Solutions, IRT & Clinical Supply Chain Solutions, Licensing & Strategic Partnering, Patient Recruitment & Diversity, Investor Readiness & Connections, Data Management & Biostatistics, and GLSA Site Nexus (a private community for clinical research site staff). Additional services include Fractional HR Services, Talent Acquisition, and Business Services. GLSA's network comprises 200+ global partners with over 100 years of combined experience, supporting organizations from early discovery through clinical trials, regulatory approval, licensing, and commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • GLSA Site Nexus: A private, curated community exclusively for Clinical Research Site Staff providing study opportunities, peer networking, on-demand experts, and site education.
  • GLSA Community Partners
  • Friends of Chris Matheus (FOCM)
  • GLSA AI Solutions
  • GLSA Accelerated Partnering
  • Women of Life Sciences (WoLS)

Products and services

  • Preclinical & IND-Enabling Solutions Discovery, translational strategy, and IND-readiness support including toxicology, pharmacology, and IND-enabling studies delivered through fractional leadership and vetted global partners for biotech and pharma sponsors.
  • Global Clinical Research Solutions End-to-end Phase I-IV clinical trial solutions delivered through global CRO partnerships, site networks, GLSA Site Nexus, eClinical systems, and specialized operational leadership for sponsors and emerging biotechs.
  • Emerging Biotech Solutions Fractionalized executive leadership and full-service preclinical and clinical solutions for emerging biotech companies, supporting development from seed through clinical-stage execution.
  • AI Drug Development & Clinical Research AI-powered predictive modeling, trial optimization, and predictive research integrating AI and machine learning across preclinical and clinical development to improve protocol optimization, feasibility, and patient matching.
  • Bioanalysis & Translational Science Strategic bioanalysis, assay development, validation, and scientific oversight supporting small molecule, large molecule, translational, and biomarker programs with regulatory readiness and data integrity.
  • eClinical Technologies Advanced eClinical systems including RTSM, EDC, AI-enabled workflows, and cybersecurity-focused technology infrastructure for digital trial execution, data integrity, and regulatory compliance.
  • Lab & Diagnostic Solutions Central labs, genomic services, biomarker strategy, and diagnostic infrastructure supporting precision medicine, translational research, and clinical trials from discovery through commercialization.
  • IRT & Clinical Supply Chain Solutions Integrated IRT, RTSM, global supply chain, cold-chain logistics, and investigational distribution solutions ensuring chain of custody, inventory transparency, and uninterrupted product delivery.
  • Licensing & Strategic Partnering Global licensing, strategic partnering, asset commercialization, investor readiness, diligence preparation, and commercialization planning for biotech and life sciences innovators.
  • Patient Recruitment, Advocacy & Diversity Patient recruitment experts, advocacy networks, call centers, and diversity-focused engagement solutions improving enrollment, retention, and representation aligned with FDA diversity initiatives.
  • GLSA Investor Readiness & Connections Investor readiness, strategic growth, and capital alignment solutions supporting funding preparation, investor engagement, partnerships, and scalable growth for life sciences companies.
  • Data Management & Biostatistics Biostatistics, clinical data management, governance, endpoint analysis, and regulatory reporting solutions improving trial precision, compliance, and strategic decision-making.
  • GLSA Site Nexus Private, curated community exclusively for Clinical Research Site Staff providing study opportunities, quick feasibility requests, peer networking, on-demand experts, and site education, certifications, and training.
  • Fractional HR Services Fractional human resources leadership and talent acquisition support for life sciences companies, including HR policy development, compliance audits, recruitment strategy, and organizational culture building.
  • Talent Acquisition & Executive Search Life sciences talent acquisition connecting organizations with high-performing teams and helping professionals find meaningful career opportunities in biotech, pharma, and life sciences.
  • Clinical Supply Chain & Logistics Consulting End-to-end clinical trial supply chain and logistics consulting including packaging, labeling, global distribution, cold-chain coordination, and last-mile delivery for investigational products.
  • Business Services Strategic marketing, brand development, go-to-market execution, organizational development, and change management for life sciences companies.
  • GLSA Network Partner Services Network of trusted CDMOs, CROs, labs, technology providers, and specialized service partners delivering end-to-end preclinical and clinical solutions to sponsors, sites, and emerging biotech companies.

Companies that use GLSA

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

GLSA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

GLSA partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, major and minor.

  • Clinical Research Sites & Site NetworkscoreStrategic or Co-development PartnerGLSA Site Nexus connects sponsors and CROs with qualified clinical research sites. Sites gain visibility, study opportunities, peer networking, and access to shared resources and educational opportunities through a private community.
  • Global Advisory NetworkcoreStrategic or Co-development PartnerSenior advisors including fractional CMOs, regulatory experts, and specialized executives providing on-demand strategic guidance across preclinical and clinical development.
  • CDMOs (Contract Development and Manufacturing Organizations)coreStrategic or Co-development PartnerManufacturing and development partners within the 200+ partner network supporting preclinical through commercial production capabilities.
  • CROs (Contract Research Organizations)coreChannel Partner/ Reseller/ DistributorGlobal CRO partnerships enabling clinical trial execution, operational support, and study management across all phases.
  • Specialized Laboratories & DiagnosticscoreTechnology or IntegrationPre-vetted lab partners for bioanalysis, biomarkers, central labs, genomics, and diagnostic services supporting translational research and clinical trials.
  • eClinical Technology ProvidersmajorTechnology or IntegrationTechnology partners providing EDC, CTMS, eCOA, ePRO, RTSM, and integrated clinical platforms for digital trial infrastructure.
  • Patient Recruitment & Advocacy PartnersmajorStrategic or Co-development PartnerDigital marketing, community engagement, and AI-supported patient matching partners helping trials accelerate enrollment and improve retention.
  • Women of Life Sciences (WoLS)minorGTM or Marketing PartnerLinkedIn community of 400+ women in life sciences with events, conversations, and networking initiatives supported by GLSA.
  • FOCM (Friends of Chris Matheus)minorGTM or Marketing PartnerNetworking membership group hosting monthly virtual events for life sciences professionals, sponsors, and GLSA community.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

GLSA competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health: Syneos Health provides clinical development and commercial services with a biopharmaceutical acceleration model. Comparable to GLSA's end-to-end positioning across clinical and commercialization, though Syneos operates owned delivery infrastructure.
  • IQVIA: IQVIA is the largest global CRO and life sciences services conglomerate, offering clinical operations, real-world evidence, and technology. Comparable to GLSA in serving sponsors and biotechs across the full clinical development lifecycle, but at vastly greater scale and with owned infrastructure rather than a partner aggregator model.
  • Charles River Laboratories: Charles River provides preclinical CRO services, CDMO capabilities, and research models. Comparable to GLSA's preclinical and IND-enabling solutions offering, though Charles River operates owned lab infrastructure at global scale.
  • Labcorp Drug Development (Fortrea): Fortrea (spun out from Labcorp) is a major CRO providing clinical development, laboratory, and commercialization services. Comparable to GLSA across clinical operations and central lab services, though at much larger scale with owned assets.
  • Medpace: Medpace is a mid-to-large CRO focused on emerging and mid-sized biotechs with full-service clinical development. Direct overlap with GLSA's primary emerging biotech segment, though Medpace operates owned regional operations versus GLSA's partner aggregator model.
  • Parexel International: Parexel is a global CRO offering clinical operations, regulatory, biostatistics, and consulting services. Comparable to GLSA across clinical research solutions and regulatory services, though Parexel operates owned global infrastructure.
  • ICON plc: ICON is a leading global CRO offering clinical research, consulting, and laboratory services across all phases. Comparable to GLSA in serving emerging biotechs and sponsors with end-to-end trial services, though ICON operates an owned-delivery model versus GLSA's partner-network aggregator approach.

Direct peers

  • WCG (WIRB-Copernicus Group): WCG provides clinical trial solutions including IRB review, site optimization, and study activation services. Comparable to GLSA Site Nexus in particular, given both focus on site enablement, study startup acceleration, and sponsor-site connections across the clinical research ecosystem.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO specializing in complex clinical trials across multiple therapeutic areas. Comparable to GLSA in targeting mid-sized biotech and emerging pharma with flexible engagement models, though Worldwide delivers via owned operations.

Emerging players

  • BioIQ (or equivalent fractional biotech services firm): BioIQ and similar fractional biotech advisory firms provide fractional leadership and operational support to emerging biotechs. Comparable to GLSA's Emerging Biotech Solutions and fractional executive offerings, though typically narrower in service scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

GLSA social profiles

Digital presence

GLSA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GLSA leadership team

Management profile

Number of profiles

Profiles14 records

GLSA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GLSA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GLSA

What does GLSA do?

GLSA (Global Life Sciences Alliance) operates a curated network of 200+ fractionalized experts, CDMOs, CROs, labs, and specialized service partners that delivers end-to-end preclinical and clinical development solutions to life sciences organizations. The company provides on-demand, project-based, or retainer consulting arrangements covering discovery, IND-enabling studies, clinical trial management, vendor selection, bioanalysis, eClinical technologies, patient recruitment, licensing, and investor connections. Its core commercial model is relationship-driven direct engagement with sponsors, biotechs, and CROs, supplemented by a private community (GLSA Site Nexus) for clinical research sites.

Is GLSA a public or private company?

GLSA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was GLSA founded?

GLSA was founded in 2020. It employs 11 to 50 people.

Where is GLSA based?

GLSA is headquartered in Philadelphia, United States, in the North America region.

How does GLSA make money?

Two revenue lines are on record. Professional Services & Consulting is the primary driver. The others are network Partnership Services.

Who are GLSA's main competitors?

Broad incumbents on record are Syneos Health, IQVIA, Charles River Laboratories, Labcorp Drug Development (Fortrea), Medpace, Parexel International and ICON plc. Direct peers are WCG (WIRB-Copernicus Group) and Worldwide Clinical Trials. BioIQ (or equivalent fractional biotech services firm) is listed as an emerging player.

Does GLSA have an API?

No public API is recorded for GLSA.

What industry is GLSA in?

GLSA's product category is Life Sciences Consulting Services. Its primary akta.pro industry code is BPAHALAH, Technical & Scientific Expert Networks. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales